Article
Development of a high-throughput barrier function assay using primary human gut organoids
2022-12-19
Abstract excerpt
Disruptions in the gut epithelial barrier can lead to the development of chronic indications such as inflammatory bowel disease (IBD). Historically, barrier function has been assessed in cancer cell lines, which do not contain all human intestinal cell types, leading to poor translatability. To bridge this gap, we adapted human primary gut organoids grown as monolayers to assess barrier function. In this work we d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2f08f454-44dd-587f-9f08-a3f44bd2417f
- DOI
- 10.1101/2022.12.16.520780
